Looareesuwan S, Ho M, Wattanagoon Y, White N J, Warrell D A, Bunnag D, Harinasuta T, Wyler D J
N Engl J Med. 1987 Sep 10;317(11):675-9. doi: 10.1056/NEJM198709103171105.
Plasmodium-infected erythrocytes lose their normal deformability and become susceptible to splenic filtration. In animal models, this is one mechanism of antimalarial defense. To assess the effect of acute falciparum malaria on splenic filtration, we measured the clearance of heated 51Cr-labeled autologous erythrocytes in 25 patients with acute falciparum malaria and in 10 uninfected controls. Two groups of patients could be distinguished. Sixteen patients had splenomegaly, markedly accelerated clearance of the labeled erythrocytes (clearance half-time, 8.4 +/- 4.4 minutes [mean +/- SD] vs. 62.5 +/- 36.5 minutes in controls; P less than 0.001), and a lower mean hematocrit than did the patients without splenomegaly (P less than 0.001). In the nine patients without splenomegaly, clearance was normal. After institution of antimalarial chemotherapy, however, the clearance in this group accelerated to supernormal rates similar to those in the patients with splenomegaly, but without the development of detectable splenomegaly. Clearance was not significantly altered by treatment in the group with splenomegaly. Six weeks later, normal clearance rates were reestablished in most patients in both groups. We conclude that splenic clearance of labeled erythrocytes is enhanced in patients with malaria if splenomegaly is present and is enhanced only after treatment if splenomegaly is absent. Whether this enhanced splenic function applies to parasite-infected erythrocytes in patients with malaria and has any clinical benefit will require further studies.
感染疟原虫的红细胞会失去其正常的可变形性,并变得易于被脾脏过滤。在动物模型中,这是抗疟疾防御的一种机制。为了评估急性恶性疟疾对脾脏过滤的影响,我们测量了25例急性恶性疟疾患者和10名未感染对照者中经加热的51Cr标记的自体红细胞的清除率。可将患者分为两组。16例患者有脾肿大,标记红细胞的清除明显加速(清除半衰期,8.4±4.4分钟[平均值±标准差],而对照组为62.5±36.5分钟;P<0.001),且平均血细胞比容低于无脾肿大的患者(P<0.001)。在9例无脾肿大的患者中,清除率正常。然而,在进行抗疟疾化疗后,该组的清除率加速至与有脾肿大患者相似的超常水平,但未出现可检测到的脾肿大。有脾肿大组的清除率未因治疗而显著改变。六周后,两组中的大多数患者恢复了正常的清除率。我们得出结论,有脾肿大的疟疾患者标记红细胞的脾脏清除率会提高,而无脾肿大的患者仅在治疗后清除率才会提高。这种增强的脾脏功能是否适用于疟疾患者中被寄生虫感染的红细胞以及是否有任何临床益处,还需要进一步研究。